Portfolio company
Chemify
United Kingdom · £36.0m raised
Raised
£36.0m
Latest stage
Series A
Rounds recorded
1
Backed by
8 investors
Sectors
About
This company provides automated molecular design and synthesis services to pharmaceutical, biotechnology and industrial partners using robotics and artificial intelligence.
SourceFunding history · 1
Similar companies
Warp Sciences
This company provides automated chemistry laboratories using robotics and artificial intelligence to synthesise and test research molecules for biotechnology and pharmaceutical organisations.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
AI-DRIVEN CHEMISTRY
This company provides a machine learning platform to help pharmaceutical and chemical organisations accelerate research and development by optimizing experiments using small datasets.
Cime Therapeutics
The company develops an automated drug discovery platform using synthetic chemistry and artificial intelligence to create therapeutic molecules for pharmaceutical organisations.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.
b-12
This company develops an artificial intelligence platform to automate chemical synthesis and laboratory experiments for pharmaceutical and biotechnology researchers.
Solve Chemistry
This company provides an automated laboratory platform and predictive software to optimise chemical process development for pharmaceutical, agrochemical and specialty chemical customers.
Qulab
This company develops artificial intelligence and quantum computing software to automate small molecule drug design for the pharmaceutical and chemical industries.
